Skip to main content

Advertisement

SpringerLink
Log in

Pediatric Osteoporosis

  • Review Article
  • Published:
Indian Journal of Orthopaedics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Gordon, C. M., Leonard, M. B., & Zemel, B. S. (2014). 2013 pediatric position development conference: executive summary and reflections. Journal of Clinical Densitometry, 17, 219–224.

    Article  PubMed  Google Scholar 

  2. Bishop, N., Arundel, P., Clark, E., et al. (2014). Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2013 Pediatric Official Positions. Journal of Clinical Densitometry, 17, 275–280.

    Article  PubMed  Google Scholar 

  3. Ott, S. M. (2018). Cortical or trabecular bone: what’s the difference? American Journal of Nephrology, 47, 373–375. https://doi.org/10.1159/000489672.[PubMed][CrossRef][GoogleScholar]

    Article  PubMed  Google Scholar 

  4. El-Gazzar, A., & Hogler, W. (2021). Mechanisms of bone fragility: from osteogenesis imperfecta to secondary osteoporosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms22020625

    Article  PubMed  PubMed Central  Google Scholar 

  5. Ganesan, K., Jandu, J. S., & Roane, D. (2021). Secondary osteoporosis. StatPearls.

    Google Scholar 

  6. McDonald, M. M., Khoo, W. H., Ng, P. Y., Xiao, Y., Zamerli, J., Thatcher, P., Kyaw, W., et al. (2021). Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption. Cell, 184(1330–347), e1313. https://doi.org/10.1016/j.cell.2021.02.002

    Article  CAS  Google Scholar 

  7. Wang, K., Ren, Y., Lin, S., Jing, Y., Ma, C., Wang, J., Yuan, X. B., Han, X., Zhao, H., Wang, Z., Zheng, M., Xiao, Y., Chen, L., Olsen, B. R., & Feng, J. Q. (2021). Osteocytes but not osteoblasts directly build mineralized bone structures. International Journal of Biological Sciences, 17, 2430–2448. https://doi.org/10.7150/ijbs.61012

    Article  PubMed  PubMed Central  Google Scholar 

  8. Thompson, W. R., Rubin, C. T., & Rubin, J. (2012). Mechanical regulation of signaling pathways in bone. Gene, 503(2), 179–193. https://doi.org/10.1016/j.gene.2012.04.076

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Genant, H. K., Wu, C. Y., van Kuijk, C., & Nevitt, M. C. (1993). Vertebral fracture assessment using a semiquantitative technique. Journal of Bone and Mineral Research, 8, 1137–1148.

    Article  CAS  PubMed  Google Scholar 

  10. Joseph, S., McCarrison, S., & Wong, S. (2016). C: Skeletal fragility in children with chronic disease. Hormone Research in Pædiatrics, 86, 71–82. https://doi.org/10.1159/000447583

    Article  CAS  PubMed  Google Scholar 

  11. Binkovitz, L. A., & Henwood, M. J. (2007). Pediatric DXA: technique and interpretation. Pediatric Radiology, 37, 21–31. https://doi.org/10.1007/s00247-006-0153-y

    Article  PubMed  Google Scholar 

  12. Hogler, W., & Ward, L. (2015). Osteoporosis in children with chronic disease. Endocrine Development, 28, 176–195.

    Article  CAS  PubMed  Google Scholar 

  13. Baroncelli, G. I., & Bertelloni, S. (2014). The use of bisphosphonates in pediatrics. Hormone Research in Pædiatrics, 82, 290–302.

    Article  CAS  PubMed  Google Scholar 

  14. Rauch, F., Munns, C. F., Land, C., Cheung, M., & Glorieux, F. H. (2009). Risedronate in the treatment of mild pediatric osteogenesis imperfecta: a randomized placebo-controlled study. Journal of Bone and Mineral Research, 24(7), 1282–1289. https://doi.org/10.1359/jbmr.090213

    Article  CAS  PubMed  Google Scholar 

  15. Simm, P. J., et al. (2018). Consensus guidelines on the use of bisphosphonate therapy in children and adolescents. Journal of Paediatrics and Child Health., 54(3), 223–233. https://doi.org/10.1111/jpc.13768

    Article  PubMed  Google Scholar 

  16. Munns, C. F., Rauch, F., Zeitlin, L., et al. (2004). Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate. Journal of Bone and Mineral Research, 19, 1779–1786.

    Article  CAS  PubMed  Google Scholar 

  17. Tuchman, S., Thayu, M., Shults, J., Zemel, B. S., Burnham, J. M., & Leonard, M. B. (2008). Interpretation of biomarkers of bone metabolism in children: impact of growth velocity and body size in healthy children and chronic disease. Journal of Pediatrics, 153, 484–490.

    Article  CAS  PubMed  Google Scholar 

  18. Gordon, C. M., Leonard, M. B., & Zemel, B. S. (2014). 2013 Pediatric position development conference: executive summary and reflections. Journal of Clinical Densitometry, 17(2), 219–224.

    Article  PubMed  Google Scholar 

  19. Vuorimies, I., Mayranpaa, M. K., Valta, H., et al. (2017). Bisphosphonate treatment and the characteristics of femoral fractures in children with osteogenesis imperfecta. Journal of Clinical Endocrinology and Metabolism, 102, 1333–1339.

    Article  PubMed  Google Scholar 

  20. Trejo, P., Fassier, F., Glorieux, F. H., et al. (2017). Diaphyseal femur fractures in osteogenesis imperfecta: characteristics and relationship with bisphosphonate treatment. Journal of Bone and Mineral Research, 32, 1034–1039.

    Article  CAS  PubMed  Google Scholar 

  21. Loizidou, A., Andronikou, S., & Burren, C. P. (2017). Pamidronate “zebra lines”: a treatment timeline. Radiol Case Rep., 12(4), 850–853. https://doi.org/10.1016/j.radcr.2017.07.003.PMID:29484085;PMCID:PMC5823313

    Article  PubMed  PubMed Central  Google Scholar 

  22. Semler, O., Netzer, C., Hoyer-Kuhn, H., et al. (2012). First use of the RANKL antibody denosumab in osteogenesis imperfecta type VI. Journal of Musculoskeletal and Neuronal Interactions, 12, 183–188.

    CAS  PubMed  Google Scholar 

  23. Hoyer-Kuhn, H., Netzer, C., Koerber, F., et al. (2014). Two years’ experience with denosumab for children with osteogenesis imperfecta type VI. Orphanet Journal of Rare Diseases, 9, 145.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Hoyer-Kuhn, H., Franklin, J., Allo, G., et al. (2016). Safety and efficacy of denosumab in children with osteogenesis imperfecta—a first prospective trial. Journal of Musculoskeletal and Neuronal Interactions, 16, 24–32.

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Kumaki, D., Nakamura, Y., Sakai, N., et al. (2018). Efficacy of denosumab for glucocorticoid-induced osteoporosis in an adolescent patient with Duchenne muscular dystrophy: a case report. JBJS Case Connect, 8, e22.

    Article  PubMed  Google Scholar 

  26. Hogler, W., Briody, J., Moore, B., et al. (2005). Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency. Bone, 37, 642–650.

    Article  PubMed  Google Scholar 

  27. Fabre, S., Funck-Brentano, T., & Cohen-Solal, M. (2020). Anti-sclerostin antibodies in osteoporosis and other bone diseases. Journal of Clinical Medicine, 9(11), 3439. https://doi.org/10.3390/jcm9113439

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Song, I. W., Nagamani, S. C., Nguyen, D., Grafe, I., Sutton, V. R., Gannon, F. H., Munivez, E., Jiang, M. M., Tran, A., Wallace, M., Esposito, P., Musaad, S., Strudthoff, E., McGuire, S., Thornton, M., Shenava, V., Rosenfeld, S., Huang, S., Shypailo, R., … Lee, B. (2022). Targeting TGF-β for treatment of osteogenesis imperfecta. The Journal of Clinical Investigation, 132(7), e152571. https://doi.org/10.1172/JCI152571

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Hogler, W., Scott, J., Bishop, N., et al. (2017). The effect of whole body vibration training on bone and muscle function in children with osteogenesis imperfecta. Journal of Clinical Endocrinology and Metabolism, 102, 2734–2743.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Park Hospital, Gurugram, Haryana, India

    Mohit Kumar Arora

Authors
  1. Mohit Kumar Arora
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mohit Kumar Arora.

Ethics declarations

Conflict of interest

The author declares no conflict of interest.

Ethical standard statement

This article does not contain any studies with human or animal subjects performed by the any of the authors.

Informed consent

For this type of study informed consent is not required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Arora, M.K. Pediatric Osteoporosis. JOIO 57 (Suppl 1), 225–229 (2023). https://doi.org/10.1007/s43465-023-01062-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s43465-023-01062-7

Keywords

Search

Navigation